GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Japan Hospice Holdings 7061.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

427

+4.40%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥14.17bn

FY2017FY2025

Net income

¥278.0m

FY2017FY2025

Free cash flow

−¥1.32bn

FY2017FY2025

Shareholders' equity

¥3.68bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥14.17bn¥12.12bn¥9.87bn¥7.89bn¥6.02bn¥4.92bn¥4.19bn¥3.02bn¥1.90bn
Gross profit¥1.84bn¥2.11bn¥1.92bn¥1.58bn¥1.12bn¥860.2m¥989.8m¥641.6m¥351.6m
Operating income¥849.0m¥1.29bn¥1.28bn¥959.3m¥598.2m¥358.5m¥501.2m¥242.8m¥49.7m
Net income¥278.0m¥639.6m¥681.9m¥454.7m¥240.8m¥107.1m¥297.9m¥149.5m−¥60.5m
Diluted earnings per share33.4076.3384.2856.2529.8313.3834.3321.07-7.15

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥18.92bn¥18.31bn¥15.16bn¥11.45bn¥9.15bn¥6.30bn¥4.69bn¥3.31bn¥3.18bn
Cash and short-term investments¥2.01bn¥1.53bn¥1.88bn¥1.51bn¥1.04bn¥959.5m¥827.7m¥386.2m¥426.8m
Total liabilities¥15.25bn¥14.86bn¥12.47bn¥9.41bn¥7.61bn¥5.04bn¥3.64bn¥2.95bn¥2.96bn
Debt¥13.18bn¥13.19bn¥10.89bn¥8.09bn¥6.67bn¥4.37bn¥2.94bn¥2.43bn¥2.57bn
Shareholders' equity¥3.68bn¥3.45bn¥2.69bn¥2.01bn¥1.54bn¥1.26bn¥1.05bn¥363.7m¥214.2m
Shares outstanding8m8m8m8m8m8m9m7m8m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥1.05bn¥835.7m¥1.13bn¥873.8m¥467.1m¥236.2m¥322.6m¥240.7m¥4.7m
Capital spending−¥2.37bn−¥3.10bn−¥2.00bn−¥533.1m−¥1.91bn−¥494.3m−¥76.1m−¥86.4m−¥72.3m
Free cash flow−¥1.32bn−¥2.27bn−¥865.3m¥340.8m−¥1.45bn−¥258.1m¥246.5m¥154.3m−¥67.6m
Dividends paid−¥124.0m—−¥2,000—−¥1.78bn−¥487.3m−¥28.5m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥3.79bn¥3.82bn¥3.81bn¥3.67bn¥3.46bn¥3.24bn¥3.24bn¥3.19bn
Gross profit¥523.0m¥534.1m¥502.2m¥611.6m¥450.2m¥277.0m¥609.0m¥631.0m
Operating income¥274.3m¥264.7m¥148.1m¥410.2m¥220.5m¥70.1m¥342.0m¥447.0m
Net income¥87.4m¥79.6m−¥26.3m¥188.7m¥60.6m¥55.0m¥202.0m¥212.0m
Diluted earnings per share10.339.40-3.1622.677.286.6124.1125.30
Total assets¥18.75bn¥18.58bn¥18.92bn¥17.75bn¥17.98bn¥17.94bn¥18.31bn¥17.63bn
Cash and short-term investments¥1.93bn¥1.78bn¥2.01bn¥1.34bn¥1.40bn¥1.42bn¥1.53bn¥1.49bn
Debt¥3.42bn¥1.28bn¥4.93bn¥1.52bn¥4.34bn¥1.47bn¥1.60bn¥1.77bn
Shareholders' equity¥3.66bn¥3.56bn¥3.68bn¥3.70bn¥3.52bn¥3.45bn¥3.45bn¥3.23bn

Financial ratios

Data as of 9 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin13.0%17.4%19.5%20.0%18.6%17.5%
Operating margin6.0%10.6%14.0%13.5%10.4%7.4%
Net margin2.0%5.3%6.9%5.8%4.0%2.2%
Return on equity7.6%18.6%25.3%22.6%15.7%8.5%
Return on assets1.5%3.5%4.5%4.0%2.6%1.7%
Free cash flow yield88.6%101.5%83.5%37.6%63.7%19.7%
Revenue growth17.0%22.7%25.1%31.2%22.4%17.2%
Earnings growth-56.5%-6.2%50.0%88.8%124.9%-64.1%
Current ratio1.34x1.27x1.91x1.75x1.06x1.74x
Debt to equity1.34x1.37x1.12x1.28x1.84x0.95x
Equity ratio19.4%18.8%17.8%17.6%16.8%20.0%
Interest coverage1.84x2.98x3.93x3.77x3.03x2.31x
Buybacks as a share of market value0.7%-3.6%-0.1%-0.1%-0.9%7.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.2%23.6%—
Operating income-4.0%18.8%—
Net income-15.1%21.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin15.0%16.9%17.2%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Price to earnings33.518.226.945.977.4127.673.1
Price to sales0.71.01.92.93.22.95.3

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 29 Dec 2025.

FY2025
Paid in the year40.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.